Following treatment with glucagon in this experiment, mice tended to decrease their hepatic Leap2 mRNA levels compared to nontreated controls, although this did not reach statistical significance ( Figure S3 A).
1
—
—
Following treatment with glucagon in this experiment, mice tended to decrease their hepatic Leap2 mRNA levels compared to nontreated controls, although this did not reach statistical significance ( Figure S3 A).